Home › Companies › Gossamer Bio, Inc. › 2024-2025
At Gossamer Bio, Inc.'s shareholder meeting held June 25, 2025, in the 2024-2025 proxy season, 78 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 235 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the Company's named executive officers… — Gossamer Bio, Inc.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Gossamer Bio, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Gossamer Bio, Inc.’s Form 8-K, filed June 25, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 25, 2025: 6 items on Gossamer Bio, Inc.’s Form 8-K, filed June 25, 2025: 3 approved · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Gossamer Bio, Inc. in the interactive database Compare manager voting policies
These tallies are Gossamer Bio, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Thomas Daniel, M.D. | 104,358,112 | -- | -- | 25,242,954 | 47,116,188 | 81% | Not verified | — |
| Elect Director: Sandra Milligan, M.D., J.D. | 104,165,685 | -- | -- | 25,435,381 | 47,116,188 | 80% | Not verified | — |
| Elect Director: Steven Nathan, M.D. | 114,441,599 | -- | -- | 15,159,467 | 47,116,188 | 88% | Not verified | — |
| 2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 | 176,512,996 | 98,411 | 105,847 | -- | -- | 99.9% | Approved | — |
| 3. The approval, on an advisory basis, of the compensation of the Company's named executive officers | 125,358,485 | 3,769,651 | 472,930 | -- | 47,116,188 | 97% | Approved | — |
| 4. The approval of the Amended and Restated 2019 Plan | 87,795,419 | 41,469,393 | 336,254 | -- | 47,116,188 | 68% | Approved | — |
Source: Gossamer Bio, Inc., Form 8-K, filed with the SEC on June 25, 2025 — read the filing on EDGAR.
Each item below shows how the 78 asset managers that disclosed a Gossamer Bio, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Sandra Milligan, M.D., J.D.
Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Sandra Milligan, M.D., J.D.”): 104,165,685 for, 25,435,381 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 10,177,717 for, 9,852,803 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 9,254,381 | Withhold |
| Fidelity | 9,024,093 | 0 | 0 | 0 | For |
| Charles Schwab | 1,150,497 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 460,000 | Withhold |
| Invesco | 0 | 0 | 0 | 41,590 | Withhold |
| PFM Multi-Manager Series Trust | 0 | 0 | 0 | 33,487 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 24,200 | Withhold |
| Victory Capital | 0 | 0 | 0 | 20,031 | Withhold |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 7,852 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 6,923 | Withhold |
| John Hancock | 0 | 0 | 0 | 4,339 | Withhold |
| Innovator ETFs Trust | 2,221 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 906 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Steven Nathan, M.D.
Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Steven Nathan, M.D.”): 114,441,599 for, 15,159,467 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 19,473,688 for, 556,832 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,254,381 | 0 | 0 | 0 | For |
| Fidelity | 9,024,093 | 0 | 0 | 0 | For |
| Charles Schwab | 1,150,497 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 460,000 | Withhold |
| Invesco | 41,590 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 0 | 0 | 0 | 33,487 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 24,200 | Withhold |
| Victory Capital | 0 | 0 | 0 | 20,031 | Withhold |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 7,852 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 6,923 | Withhold |
| John Hancock | 0 | 0 | 0 | 4,339 | Withhold |
| Innovator ETFs Trust | 2,221 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 906 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
81% Majority: yes · of votes cast
Description as filed by funds: Election of Class I Directors: Thomas Daniel, M.D.
Gossamer Bio, Inc.’s own tally for this item (“Elect Director: Thomas Daniel, M.D.”): 104,358,112 for, 25,242,954 withheld, per its Form 8-K filed June 25, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 81% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 10,219,307 for, 9,811,213 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 9,254,381 | Withhold |
| Fidelity | 9,024,093 | 0 | 0 | 0 | For |
| Charles Schwab | 1,150,497 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 460,000 | Withhold |
| Invesco | 41,590 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 0 | 0 | 0 | 33,487 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 24,200 | Withhold |
| Victory Capital | 0 | 0 | 0 | 20,031 | Withhold |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 7,852 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 6,923 | Withhold |
| John Hancock | 0 | 0 | 0 | 4,339 | Withhold |
| Innovator ETFs Trust | 2,221 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 906 | 0 | 0 | 0 | For |
68% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2019 INCENTIVE AWARD PLAN.
Gossamer Bio, Inc.’s own tally for this item (“4. The approval of the Amended and Restated 2019 Plan”): 87,795,419 for, 41,469,393 against — passed, per its Form 8-K filed June 25, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Amended and Restated 2019 Plan was approved by the votes indicated:”
Support: 68% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 9,254,381 | 0 | 0 | Against |
| Fidelity | 0 | 9,024,093 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,150,497 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 460,000 | 0 | 0 | Against |
| Invesco | 0 | 41,590 | 0 | 0 | Against |
| PFM Multi-Manager Series Trust | 0 | 33,487 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 24,200 | 0 | 0 | Against |
| Victory Capital | 0 | 20,031 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 7,852 | 0 | 0 | Against |
| Goldman Sachs | 0 | 6,923 | 0 | 0 | Against |
| John Hancock | 0 | 4,339 | 0 | 0 | Against |
| Innovator ETFs Trust | 2,221 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 906 | 0 | 0 | 0 | For |
Fund voting reports, all 13 managers: 3,127 for, 20,027,393 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 18,093,034 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 18,093,034 for.
Combines 4 wordings of this item as funds reported it.
97% Approved · of votes cast
Description as filed by funds: Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.
Gossamer Bio, Inc.’s own tally for this item (“3. The approval, on an advisory basis, of the compensation of the Company's named executive officers”): 125,358,485 for, 3,769,651 against — passed, per its Form 8-K filed June 25, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The compensation of the named executive officers was approved, on an advisory basis, by the votes indicated:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,254,381 | 0 | 0 | 0 | For |
| Fidelity | 9,024,093 | 0 | 0 | 0 | For |
| Charles Schwab | 1,150,497 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 460,000 | 0 | 0 | 0 | For |
| Invesco | 41,590 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 33,487 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 24,200 | 0 | 0 | 0 | For |
| Victory Capital | 20,031 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 7,852 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,923 | 0 | 0 | 0 | For |
| John Hancock | 4,339 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 2,221 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 906 | 0 | 0 | 0 | For |
Fund voting reports, all 13 managers: 20,030,520 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 18,093,034 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 17,028,613 | 0 | 0 | 0 | For |
| Fidelity | 7,090,793 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 5,808,875 | 0 | 0 | 0 | For |
| HHLR ADVISORS, LTD. | 4,974,041 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,684,103 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 0 | 0 | 0 | 0 | Not Voted |
| Rock Springs Capital Management LP | 3,266,960 | 0 | 0 | 0 | For |
| Samsara BioCapital, LLC | 3,119,396 | 0 | 0 | 0 | For |
| Opaleye Management Inc. | 2,904,998 | 0 | 0 | 0 | For |
| Laurion Capital Management LP | 2,487,477 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,301,250 | 0 | 0 | 0 | For |
| BlackRock | 1,987,921 | 0 | 0 | 0 | For |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,518,221 | 0 | 0 | 0 | For |
| Charles Schwab | 1,150,497 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 1,022,115 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 907,854 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 832,160 | 0 | 0 | 0 | For |
| State Street | 807,376 | 0 | 0 | 0 | For |
| Corient Private Wealth LLC | 741,970 | 0 | 0 | 0 | For |
| Woodline Partners LP | 728,459 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 0 | 720,132 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 0 | 659,531 | 0 | 0 | Against |
| Atom Investors LP | 578,065 | 0 | 0 | 0 | For |
| OMERS ADMINISTRATION Corp | 489,100 | 0 | 0 | 0 | For |
Institutional-manager reports, all 70 managers: 84,003,412 for, 2,135,076 against, 3,423,546 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE YEAR ENDING DECEMBER 31, 2025.
Gossamer Bio, Inc.’s own tally for this item (“2. The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 176,512,996 for, 98,411 against — passed, per its Form 8-K filed June 25, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The selection was ratified by the votes indicated:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 20,030,520 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 9,254,381 | 0 | 0 | 0 | For |
| Fidelity | 9,024,093 | 0 | 0 | 0 | For |
| Charles Schwab | 1,150,497 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 460,000 | 0 | 0 | 0 | For |
| Invesco | 41,590 | 0 | 0 | 0 | For |
| PFM Multi-Manager Series Trust | 33,487 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 24,200 | 0 | 0 | 0 | For |
| Victory Capital | 20,031 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 7,852 | 0 | 0 | 0 | For |
| Goldman Sachs | 6,923 | 0 | 0 | 0 | For |
| John Hancock | 4,339 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 2,221 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 906 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 227,302,140 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.07% |
| 2 | Fidelity | 3.97% |
| 3 | Charles Schwab | 0.51% |
| 4 | BRIDGEWAY FUNDS INC | 0.20% |
| 5 | Invesco | 0.02% |
| 6 | PFM Multi-Manager Series Trust | 0.01% |
| 7 | Blackstone Alternative Investment Funds | 0.01% |
| 8 | Victory Capital | <0.01% |
| 9 | PACE SELECT ADVISORS TRUST | <0.01% |
| 10 | Goldman Sachs | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | NEA Management Company, LLC | 7.96% |
| 2 | Octagon Capital Advisors LP | 7.49% |
| 3 | Fidelity | 3.12% |
| 4 | Palo Alto Investors LP | 2.56% |
| 5 | HHLR ADVISORS, LTD. | 2.19% |
| 6 | SILVERARC CAPITAL MANAGEMENT, LLC | 1.62% |
| 7 | Eversept Partners, LP | 1.51% |
| 8 | Rock Springs Capital Management LP | 1.44% |
| 9 | Samsara BioCapital, LLC | 1.37% |
| 10 | Opaleye Management Inc. | 1.28% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| 683 Capital Management, LLC | — | 13G |
| Context Capital Management, LLC | — | 13G |
| D. E. Shaw & Co., L.L.C. | — | 13D |
| DeepCurrents Investment Group LLC | — | 13G |
| Vanguard Group | — | 13F |
| Octagon Capital Advisors LP | — | 13G |
| Faheem Hasnain | — | DEF14A |
| FMR (Fidelity) | — | 13F |
| Invus Public Equities, L.P. | — | 13G |
| Growth Equity Opportunities 18 VGE, LLC | — | 13D |
Percentages above are of 227,302,140 shares outstanding, as reported by Gossamer Bio, Inc. on its Form 10-Q dated May 12, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Gossamer Bio, Inc.’s 10-Q dated May 12, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Gossamer Bio, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “Gossamer Bio (GOSS) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/gossamer-bio-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.